Stock HWEL HEALTHWELL ACQUISITION CORP. I
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Healthwell Acquisition Corp. I

Equities

HWEL

US42227R1095

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HEALTHWELL ACQUISITION CORP. I ANNOUNCES CANCELLATION OF SPECIAL STOCKHOLDER MEETING AND ITS INTENTION TO LIQUIDATE
AQ
Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate
BU
Starton Therapeutics Announces Termination of Business Combination Agreement with Healthwell Acquisition Corp. I
AQ
Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.
BU
Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions
BU
Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions
BU
Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma
BU
Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple Myeloma
BU
Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma
BU
Healthwell Acquisition I : Shareholder Director Nominations - Form 8-K
PU
HEALTHWELL ACQUISITION CORP. I : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma
BU
Starton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare Conference
BU
HEALTHWELL ACQUISITION CORP. I : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
HEALTHWELL ACQUISITION CORP. I : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
HEALTHWELL ACQUISITION CORP. I : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Starton Therapeutics Inc. and Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer Treatments
BU
HEALTHWELL ACQUISITION CORP. I : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
HEALTHWELL ACQUISITION CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
HEALTHWELL ACQUISITION CORP. I MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HWEL Stock
  4. News Healthwell Acquisition Corp. I
  5. Press Releases